ArticleBMC immunology2026
A combined model based on lactate clearance rate and SOFA score in prognostic assessment of patients with severe pneumonia.
Article in BMC immunology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo investigate the role of lactate clearance rate (LCR) and Sequential Organ Failure Assessment (SOFA) score in prognostic assessment of patients with severe pneumonia (SP).
methodsA retrospective study of 185 SP patients was conducted. Baseline characteristics were compared between survivors (n = 128) and non-survivors (n = 57). Following univariate and correlation analyses, significant variables were used to build a combined prediction model via binary logistic regression. Model calibration and predictive performance for 28-day mortality were assessed using Hosmer-Lemeshow and ROC curve analyses, respectively. Dynamic changes in LCR and SOFA scores at admission (T0), 6 h (T6), and 24 h (T24) were compared.
resultsThe 28-day mortality rate was 30.81% (57/185). Univariate analysis revealed statistically significant differences in age, chronic lung disease, procalcitonin (PCT), LCR, and SOFA score (P < 0.05). Spearman correlation analysis showed a moderate negative correlation between LCR and SOFA score (r = -0.401, P < 0.001). Multivariate analysis identified LCR [0.911 (0.861–0.965)] and SOFA score [1.508 (1.278–1.779)] as independent predictors (P < 0.05). The combined model demonstrated superior predictive accuracy (AUC: 0.882, 95% CI: 0.833–0.932) compared to LCR (AUC: 0.793) or SOFA score (AUC: 0.832) alone (Delong test, P < 0.05). Survivors exhibited significantly higher LCR and lower SOFA scores at T6 and T24, with improving trends over time, unlike non-survivors.
conclusionThe combined model integrating LCR and SOFA score outperforms either parameter alone in predicting 28-day mortality risk in SP, offering a potential tool for early risk stratification.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.